Tozorakimab

2 trends tracked about this subject — the full history, oldest to newest below.

◼ Archived Business 🔮 fades ✓

AstraZeneca reports positive Phase III trial results for tozorakimab, a drug targeting COPD exacerbations.

2 sources 2 articles v 1 45d ago

◼ Archived Business 🔮 fades ✓

AstraZeneca reports significant Phase III trial wins for Tozorakimab, a COPD drug showing broad benefits for current and former smokers.

5 sources 5 articles v 3 46d ago